全文获取类型
收费全文 | 1669篇 |
免费 | 76篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 67篇 |
妇产科学 | 16篇 |
基础医学 | 143篇 |
口腔科学 | 73篇 |
临床医学 | 127篇 |
内科学 | 245篇 |
皮肤病学 | 52篇 |
神经病学 | 72篇 |
特种医学 | 549篇 |
外国民族医学 | 1篇 |
外科学 | 124篇 |
综合类 | 62篇 |
预防医学 | 69篇 |
眼科学 | 16篇 |
药学 | 35篇 |
中国医学 | 6篇 |
肿瘤学 | 82篇 |
出版年
2023年 | 6篇 |
2022年 | 12篇 |
2021年 | 28篇 |
2020年 | 30篇 |
2019年 | 36篇 |
2018年 | 27篇 |
2017年 | 25篇 |
2016年 | 28篇 |
2015年 | 34篇 |
2014年 | 62篇 |
2013年 | 67篇 |
2012年 | 78篇 |
2011年 | 78篇 |
2010年 | 75篇 |
2009年 | 72篇 |
2008年 | 69篇 |
2007年 | 83篇 |
2006年 | 47篇 |
2005年 | 48篇 |
2004年 | 52篇 |
2003年 | 44篇 |
2002年 | 46篇 |
2001年 | 49篇 |
2000年 | 37篇 |
1999年 | 29篇 |
1998年 | 37篇 |
1997年 | 38篇 |
1996年 | 39篇 |
1995年 | 38篇 |
1994年 | 24篇 |
1993年 | 25篇 |
1992年 | 19篇 |
1991年 | 31篇 |
1990年 | 21篇 |
1989年 | 34篇 |
1988年 | 26篇 |
1987年 | 32篇 |
1986年 | 24篇 |
1985年 | 29篇 |
1984年 | 21篇 |
1983年 | 22篇 |
1982年 | 18篇 |
1981年 | 17篇 |
1980年 | 19篇 |
1979年 | 6篇 |
1978年 | 11篇 |
1977年 | 8篇 |
1976年 | 14篇 |
1975年 | 6篇 |
1969年 | 5篇 |
排序方式: 共有1750条查询结果,搜索用时 15 毫秒
1.
2.
Slowly progressive aphasia without generalized dementia: studies with positron emission tomography 总被引:14,自引:0,他引:14
J B Chawluk M M Mesulam H Hurtig M Kushner S Weintraub A Saykin N Rubin A Alavi M Reivich 《Annals of neurology》1986,19(1):68-74
Slowly progressive aphasia without generalized dementia is a degenerative syndrome selectively affecting dominant hemisphere language areas. We report changes in regional glucose metabolism measured by positron emission tomography in two patients with this condition. Striking abnormalities of glucose utilization in the left cerebral cortex were demonstrated in both patients. The findings of other neurodiagnostic studies were relatively unremarkable. The first patient had a 3-year history of progressive anomia and impaired auditory verbal recall. An electroencephalogram was normal, and computed tomography showed mild left perisylvian atrophy. Positron emission tomography revealed profound hypometabolism in the left temporal regions. The second patient also had a 3-year history of progressive anomia. Electroencephalography, computed tomography, and magnetic resonance imaging scans were normal. Positron emission tomography showed a major reduction in left parietal glucose utilization, with a lesser decrement in left temporal metabolism. Neither patient demonstrated significant contralateral or global abnormalities such as those reported in positron emission tomographic studies of Alzheimer's disease with or without focal clinical features. These observations support the concept of adult-onset progressive aphasia without dementia as a clinical syndrome distinct from Alzheimer's disease. 相似文献
3.
4.
E MOLKE JENSEN K. A. THIESSEN AA. CHRISTENSEN 《Acta anaesthesiologica Scandinavica》1986,30(2):109-110
The effect of 4 mg oral naloxone on preoperative gastric volume and pH of gastric aspirate was studied in a double-blind, randomized study. Twenty patients received 10 ml of naloxone (4 mg) mixed with 10 ml of orange juice, and 20 patients received 10 ml of isotonic saline mixed with 10 ml of orange juice, 2 h before surgery. Gastric content was obtained immediately after intubation of the trachea. No significant difference in gastric volume and pH of gastric aspirate was found between the two groups. It is concluded that naloxone does not affect gastric emptying and gastric acid secretion to a degree great enough to protect against aspiration of gastric contents into the lungs. 相似文献
5.
6.
7.
8.
PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog. 总被引:13,自引:0,他引:13
Mathew L Thakur Mohan R Aruva Jean Gariepy Paul Acton Satish Rattan Shyam Prasad Eric Wickstrom Abass Alavi 《Journal of nuclear medicine》2004,45(8):1381-1389
The purpose of this study was to assess the feasibility of PET imaging of oncogene VPAC1 receptors overexpressed in human breast cancer cells. METHODS: Vasoactive intestinal peptide (VIP) analog (TP3982) was synthesized to harbor a carboxy-terminus lysine (Lys) residue separated from VIP-asparagine (Asn(28)) by 4-aminobutyric acid (Aba) as a spacer. Lys was derivatized with diaminopropionic acid coupled to a pair of dibenzoylthioglycolic acid residues as protecting groups. The analog was labeled with (64)Cu at pH 9 ((64)Cu-TP3982) and (99m)Tc at pH 12 ((99m)Tc-TP3982). (99m)Tc-TP3982 and VIP derivatized with Aba-GAGG and labeled with (99m)Tc ((99m)Tc-TP3654) were used as reference agents. Smooth muscle relaxivity assays performed with each derivative and compared with unaltered VIP(28) demonstrated functional integrity. In vitro stability of (64)Cu-TP3982 was determined by challenging the complex with 100-mol excess of diethylenetriaminepentaacetic acid (DTPA), human serum albumin (HSA), and cysteine. In vivo stability was determined in urine and serum for up to 24 h. The mass of the Cu-TP3982 complex was determined by mass spectrometry. Human T47D breast tumor xenografts were grown in athymic nude mice. Planar scintigraphic imaging was performed at 4 and 24 h after the intravenous administration of (99m)Tc-TP3982 and (99m)Tc-TP3654 and PET imaging was performed using a small animal MOSAIC PET scanner, also at 4 and 24 h after injection of (64)Cu-TP3982. Tissue-distribution studies were also performed. In a separate experiment, receptors were blocked by intravenous injection of authentic VIP(28) 30 min before the administration of (64)Cu-TP3982 and tissue distribution was examined. RESULTS: (64)Cu-TP3982 labeling yields were 98% +/- 1.2% and those for (99m)Tc-TP3982 and (99m)Tc-TP3654 were 98.2% +/- 1.1% and 97% +/- 1.6%, respectively. The biologic activity of both VIP analogs was uncompromised. When (64)Cu-TP3982 was challenged with 100-mol excess of DTPA, HSA, or cysteine, >98% radioactivity remained as (64)Cu-TP3982. In vivo, >98% of (64)Cu circulating in plasma remained as (64)Cu-TP3982. Of the (64)Cu excreted in urine 4, 20, and 24 h after injection, >98%, 89.9% +/- 0.9%, and 85% +/- 3%, respectively, were bound to TP3982. The mass of Cu-TP3982 as determined by surface-enhanced laser desorption/ionization time of flight (SELDI-TOF) was 4,049.7 Da. Four hours after receptor blocking with VIP(28), there was a significant reduction in uptake of all tissues except in the liver. With (64)Cu-TP3982, the 4-h postinjection tumor uptake was 10.8 +/- 2.1 %ID/g versus 0.5 +/- 0.02 %ID/g and 0.24 +/- 0.08 %ID/g for (99m)Tc-TP3982 and (99m)Tc-TP3654, respectively. Twenty-four hours after injection, the corresponding numbers were 17 +/- 0.7 %ID/g, 0.77 +/- 0.1 %ID/g, and 0.23 +/- 0.1 %ID/g. The severalfold greater uptake (21.2-74) of (64)Cu-TP3982 is attributable to the in vivo stability of the agent. CONCLUSION: The results suggest that the uncompromised biologic activity and the significantly greater tumor uptake of (64)Cu-TP3982, combined with the high sensitivity and enhanced resolution of PET imaging, make (64)Cu-TP3982 highly desirable for further studies in PET imaging of oncogene receptors overexpressed in breast and other types of cancers. 相似文献
9.
10.